Friday, November 19, 2004

Premature Birth May Predispose to Insulin Resistance ...

"Premature birth, even with normal size for gestational age, may be a risk factor for insulin resistance developing in childhood, according to the results of a study published in the Nov. 18 issue of the New England Journal of Medicine."

Thursday, November 18, 2004

Improved Outcome of Antihypertensive Therapy Associated With ...

Analysis of the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) study and substudy published in the Nov. 17 issue of JAMA showed that improved outcome of antihypertensive therapy was associated with reduction in left ventricular hypertrophy (LVH) either by electrical criteria or echocardiography. The editorialist suggests that while we are awaiting the definitive study, it may be appropriate to evaluate LVH during antihypertensive therapy."

High Selenium Linked to Lower Colorectal Adenoma Risk

"Higher blood levels of selenium are associated with lower rates of colorectal neoplasia, the results of a study in the November 17th issue of the Journal of the National Cancer Institute suggest."

High Selenium Linked to Lower Colorectal Adenoma Risk

"Higher blood levels of selenium are associated with lower rates of colorectal neoplasia, the results of a study in the November 17th issue of the Journal of the National Cancer Institute suggest."

Wednesday, November 17, 2004

Bone Marrow Cell Transfer Improves LVEF After MI

"Preliminary findings reported last year of bone marrow stem cell transfer to boost heart function after intervention for ST-segment elevation myocardial infarction (STEMI) appear to be holding up over the longer term. The 18-month results of the Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration Trial (BOOST) show on magnetic resonance imaging (MRI) that left ventricular ejection fraction (LVEF) remains better than controls."

Even in Elderly, Suggested Target INR Should Be 2.5

"Even for those older than 85 years, the target international normalized ratio (INR) for patients anticoagulated with warfarin for atrial fibrillation should be 2.5, according to the results of a case-control study published in the Nov. 16 issue of the Annals of Internal Medicine. The risks of intracranial hemorrhage (ICH) were not reduced with low-dose warfarin in this age group."